62 related articles for article (PubMed ID: 24662299)
1. Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV-infected women treated by large loop excision of the transformation zone (LLETZ).
Russomano F; Reis A; Camargo MJ; Grinsztejn B; Tristão MA
Sao Paulo Med J; 2008 Jan; 126(1):17-22. PubMed ID: 18425282
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women treated by means of electrosurgical excision of the transformation zone (LLETZ) in Rio de Janeiro, Brazil.
Russomano F; Paz BR; Camargo MJ; Grinstejn BG; Friedman RK; Tristao MA; Oliveira CA
Sao Paulo Med J; 2013; 131(6):405-10. PubMed ID: 24346780
[TBL] [Abstract][Full Text] [Related]
3. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Clifford GM; Franceschi S; Keiser O; Schöni-Affolter F; Lise M; Dehler S; Levi F; Mousavi M; Bouchardy C; Wolfensberger A; Darling KE; Staehelin C; Bertisch B; Kuenzli E; Bernasconi E; Pawlita M; Egger M;
Int J Cancer; 2016 Apr; 138(7):1732-40. PubMed ID: 26537763
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, acceptability and safety of ablative versus excisional procedure in the treatment of histologically confirmed CIN2/3: A systematic review.
Zhang L; Sauvaget C; Mosquera I; Basu P
BJOG; 2023 Jan; 130(2):153-161. PubMed ID: 35689493
[TBL] [Abstract][Full Text] [Related]
5. Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening.
Abraham AG; Strickler HD; D'Souza G
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e163. PubMed ID: 24135779
[No Abstract] [Full Text] [Related]
6. Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.
Bittencourt DD; Zanine RM; Sebastião APM; Ribas CM
Rev Col Bras Cir; 2023; 50():e20233537. PubMed ID: 38055549
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with adherence to post-treatment follow-up among a cohort of women with acetic acid/Lugol's iodine positive lesions of the cervix in Cameroon: A retrospective cohort study.
Manga SM; Nkfusai JF; Nulah KL; Manjuh F; Fokom-Domgue J; Ye Y
Gynecol Oncol Rep; 2023 Oct; 49():101269. PubMed ID: 37727369
[TBL] [Abstract][Full Text] [Related]
8. Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
Ding T; Li L; Duan R; Chen Y; Yang B; Xi M
Int J Gynaecol Obstet; 2023 Feb; 160(2):538-547. PubMed ID: 35810389
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer prevention and control in women living with human immunodeficiency virus.
Castle PE; Einstein MH; Sahasrabuddhe VV
CA Cancer J Clin; 2021 Nov; 71(6):505-526. PubMed ID: 34499351
[TBL] [Abstract][Full Text] [Related]
10. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.
Finocchario-Kessler S; Wexler C; Maloba M; Mabachi N; Ndikum-Moffor F; Bukusi E
BMC Womens Health; 2016 Jun; 16():29. PubMed ID: 27259656
[TBL] [Abstract][Full Text] [Related]
12. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus.
Robinson WR; Hamilton CA; Michaels SH; Kissinger P
Am J Obstet Gynecol; 2001 Mar; 184(4):538-43. PubMed ID: 11262450
[TBL] [Abstract][Full Text] [Related]
13. Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women.
Huchko MJ; Leslie H; Maloba M; Zakaras J; Bukusi E; Cohen CR
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):200-5. PubMed ID: 25647529
[TBL] [Abstract][Full Text] [Related]
14. Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women.
Danso D; Lyons F; Bradbeer C
Int J STD AIDS; 2006 Sep; 17(9):579-84; quiz 585-7. PubMed ID: 16942648
[TBL] [Abstract][Full Text] [Related]
15. Incidence and progression of cervical lesions in women with HIV: a systematic global review.
Denslow SA; Rositch AF; Firnhaber C; Ting J; Smith JS
Int J STD AIDS; 2014 Mar; 25(3):163-77. PubMed ID: 24216030
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Maloba M; Bukusi EA; Cohen CR
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):188-92. PubMed ID: 24662299
[TBL] [Abstract][Full Text] [Related]
17. Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
Huchko MJ; Woo VG; Liegler T; Leslie H; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
BJOG; 2013 Sep; 120(10):1233-9. PubMed ID: 23647852
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
